Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» November 2011
November 2011
Roche, PTC strike potential $490M deal for genetic disease program
Roche, PTC strike potential $490M deal for genetic disease program
Fierce Biotech
Roche
PTC Therapeutics
spinal muscular atrophy
Inhibitex rallies after reporting data from Hepatitis C Phase 1b trial
Inhibitex rallies after reporting data from Hepatitis C Phase 1b trial
Yahoo/Fly on the Wall
Inhibitex
hepatitis C
INX-189
China prepares for big entry into vaccine market
China prepares for big entry into vaccine market
Yahoo/AP
vaccines
China
FDA accepts Horizon Pharma's Lodotra application
FDA accepts Horizon Pharma's Lodotra application
Yahoo/AP
FDA
Horizon Phamra
Lodotra
rheumatoid arthritis
Sanofi antibiotics partner Rib-X aims for $80M IPO
Sanofi antibiotics partner Rib-X aims for $80M IPO
Fierce Biotech
Sanofi
antibiotics
Rib-X Pharmaceuticals
IPO
22 Hot Drugs Facing FDA Approval in 2012
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Amarin
AMR101
Ironwood
linaclotide
Merck
Ariad
ridaforolimus
Vivus
Qnexa
Avanafil
Amgen
Xgeva
Cell Therapeutics
pixantrone
Kalydeco
Vertex
ONYX Pharmaceuticals
Carfilzomib
Pfizer
Bristol-Myers Squibb
Eliquis
Chelsea Therapeutics
Northera
Levadex
MAP Pharmaceuticals
Roche
Curis
vismodegib
Biogen Idec
Elan
Tysabri
Amylin
Bydureon
Dapagliflozin
Uplypso
Protalix BioTherapeutics
Teva Pharmaceuticals
BioSante
Bio-T-Gel
Corlux
Corcept Therapeutics
Discovery Labs
Surfaxin
Micromet starts mid-stage trial of leukemia treatment blinatumomab, its most advanced drug
Micromet starts mid-stage trial of leukemia treatment blinatumomab, its most advanced drug
Yahoo/AP
blinatumomab
Micromet
leukemia
FDA clears $60M BioMarin drug-making plant expansion
FDA clears $60M BioMarin drug-making plant expansion
Bizjournals.com
FDA
Biomarin
5 Biotechs Posting Big Gains
5 Biotechs Posting Big Gains
Motley Fool
ONYX Pharmaceuticals
Momenta
Micromet
Avanir
Arena Pharmaceuticals
Onyx Pharmaceuticals Said to Weigh Sale as It Explores Strategic Options
Onyx Pharmaceuticals Said to Weigh Sale as It Explores Strategic Options
Bloomberg
ONYX Pharmaceuticals
Nexavar
M&A
Carfilzomib
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »